NIEHS Repository of Stored Biological Samples for Future Use
NCT ID: NCT05666739
Last Updated: 2025-05-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
2000 participants
OBSERVATIONAL
2024-07-15
2032-07-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Laboratory tests that use blood and urine can provide a great deal of information about human health and disease. To develop even better tests and to improve the ways samples are handled for testing researchers need to experiment with samples from healthy people.
Objective:
This natural history study will collect blood and urine from healthy people. The samples will build a repository that will be used for all kinds of research.
Eligibility:
Healthy people aged 18 years or older.
Design:
Participants will have 1 study visit. The visit will last up to 2 hours.
Participants will be screened. They will answer questions about their health history. They will list any medications they take. They will consent to donate samples for research and future use:
Blood: Up to 4.5 tablespoons of blood may be collected from a needle inserted into a vein.
Urine: Participants will be given a sterile container to provide a sample.
Some participants may be asked to provide other types of samples.
Some participants may be asked to provide new samples if their first ones are depleted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Whole Blood Specimen Collection From Healthy Subjects
NCT02797743
Blood Specimen Collection For Laboratory Assay Research
NCT06046651
Reverse Phenotyping Core
NCT03632239
BioGene Bank Cohort Study for Approved Research Requests
NCT02550171
Collection and Storage of Human Biospecimens for Research Into Rare Diseases and Medical Conditions
NCT02365376
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
We aim to build a repository utilizing both prospectively and retrospectively collected human biological samples, like blood and urine, to develop and test the following: specific laboratory assays, to develop and maintain freezer and specimen handling quality control, to have blinded quality control specimens for laboratory testing, and to assess exposure variability over time.
Objectives:
Primary Objective: To build a repository for approved investigators to access stored biological samples for the following: developing and testing specific laboratory assays, to maintain freezer and specimen handling quality control, to have blinded quality control specimens for testing labs, and to assess exposure variability over time.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
healthy controls
General public population, including females and males, who are over the age of 18, with a mixture of races and ethnicities representative of North Carolina
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Stated willingness to comply with all study procedures and availability for the duration of the study.
2. Ability to provide informed consent.
3. Male or female, aged \>=18
4. Able to travel to the NIEHS CRU for study visits
Exclusion Criteria
1. Not willing to have samples stored for future use.
2. Any condition that, in the investigator s opinion, places the participant at undue risk for complications associated with required study procedures.
18 Years
100 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Environmental Health Sciences (NIEHS)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lawrence S Kirschner, M.D.
Role: PRINCIPAL_INVESTIGATOR
National Institute of Environmental Health Sciences (NIEHS)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NIEHS Clinical Research Unit (CRU)
Research Triangle Park, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Related Links
Access external resources that provide additional context or updates about the study.
NIH Clinical Center Detailed Web Page
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
001073-E
Identifier Type: -
Identifier Source: secondary_id
10001073
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.